Navigation Links
Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
Date:12/16/2009

WALTHAM, Mass., Dec. 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, health care reforms in China supported rapid expansion of the Chinese drug-eluting stent market in 2009, and will continue to fuel growth in the coming years. MRG's new Asia Pacific Markets for Interventional Cardiology Devices 2010 report finds that initiatives undertaken by the Chinese government will allow the Chinese drug-eluting stent market to reach a value of more than $900 million by 2014.

The potential Chinese patient population for coronary stenting has historically been underpenetrated due to the high cost of the devices. Despite a rising incidence of coronary artery disease in the country, many patients choose to forego a coronary intervention due to a lack of insurance coverage and an inability to privately finance these procedures. In April 2009, the Chinese government unveiled its plans for a universal health care plan, a component of part of its Healthy China 2020 plan, which was first announced in January 2008. The healthcare reforms will increase access to premium-priced procedures and have huge implications for the drug-eluting stent market.

"This amount of funding earmarked for a public health care system will vastly expand the volume of drug-eluting stent procedures performed in China," says Dan Whalen, Analyst at MRG. "With more people able to afford the procedure, this market is expected to grow an average of nearly 20% per year over the next five years, which presents a huge opportunity for new and emerging drug-eluting stent manufacturers in the region."

MRG's new report, Asia Pacific Markets for Interventional Cardiology Devices 2010, provides critical insight into trends that will fuel market growth for coronary stents, PTCA balloon catheters, and accessory devices through 2014. In addition to China, the report als
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
6. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
7. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
10. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
11. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... 2011 Cynosure, Inc. (Nasdaq: CYNO ), ... invasive and non-invasive aesthetic applications, today announced that two ... cellulite reduction have received key international regulatory clearances. ... License authorizing the sale in Canada of the company,s ...
... SANTA CLARA, Calif., March 15, 2011 NewCardio, Inc. (OTC Bulletin ... today that the Company expects to file its Form 10-K for ... management will conduct a conference call to provide a corporate update ... Corporate Update Conference Call When : 1:30 p.m. ...
Cached Medicine Technology:Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 2Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 3NewCardio to Conduct Corporate Update Conference Call on March 29, 2011 2
(Date:8/30/2014)... 2014: The first recommendations on the use of ... published today in new ESC Guidelines. The guidelines ... V. Konstantinides (Germany/Greece) and Professor Adam Torbicki (Poland). ... and management of acute pulmonary embolism" are published ... on the ESC Website. , Venous thromboembolism (VTE) ...
(Date:8/29/2014)... The Enchant Him review that was recently published by ... system that promises to teach ladies how to gain control ... who actually is a popular relationship expert and coach. ... advices out there, Carrie worked at this program with Nick ... is a simple to use step by step method. This ...
(Date:8/29/2014)... 29, 2014 The Fibroids Miracle review indicates ... naturally. The program promises fast and powerful results. It actually ... caused by fibroids in only 12 hours. The method promises ... The new system is based on a 3 step method ... its review that the program was in fact created by ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 According to ... popular hardware detection tool at the moment, as it is ... the best hardware detection tool in the industry. , ... any customer hardware driver. The new program is highly effective ... devices to work perfectly. , Daily Gossip writes in ...
(Date:8/29/2014)... Cosmetic Town has devised a system ... its doctors. Cosmetic Town utilizes a validated referral ... in their field are chosen to present their procedure. ... direct link to potentially hundreds of recommended doctors in ... to communicate through the site’s community features and multimedia ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2Health News:Fibroids Miracle Review Exposes Amanda Leto’s 3-Step Holistic System 2Health News:Driver Robot Review Exposes Popular Hardware Detection Tool 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2
... resistant to targeted therapy drugs has revealed two previously ... March 23 Science Translational Medicine , investigators from ... how the cellular nature of some tumors actually changes ... can disappear after treatment is discontinued. The findings ...
... , WEDNESDAY, March 23 (HealthDay News) -- ... become resistant to targeted drug therapy. Researchers at ... from 37 patients with non-small cell lung cancer, the ... new genetic changes associated with resistance. They also ...
... study of its kind, urologists and biostatisticians at Henry Ford ... glands is safe over the long term, with a major ... published online this month by the journal European Urology, ... 87 percent of patients whose cancerous prostates were removed by ...
... , TUESDAY, March 22 (HealthDay News) -- Trauma injury patients ... weeknight are no more likely to die than those who ... The findings contrast with previous research that said patients with ... outcomes if they arrive at the hospital at night or ...
... every year there are reports of a young, apparently healthy athlete ... of Wes Leonard, a junior at Fennville High School, who died ... have parents and coaches wondering if enough is being done to ... to develop a better screening program to help prevent sudden cardiac ...
... at Virginia Commonwealth University Massey Cancer Center and VCU ... mechanism in gene regulation that contributes to the development ... (HCC). Currently, there is virtually no effective treatment for ... for therapeutic intervention. In the journal ...
Cached Medicine News:Health News:Mass. General study reveals how lung cancers evolve in response to targeted treatment 2Health News:Mass. General study reveals how lung cancers evolve in response to targeted treatment 3Health News:Lung Cancer Evolves With Treatment, Study Finds 2Health News:Long-term study: Robot-assisted prostate surgery is safe 2Health News:Trauma Patients Seem More Likely to Survive on Weekends 2Health News:Do all student athletes need heart screenings? 2Health News:Do all student athletes need heart screenings? 3Health News:Discovery in liver cancer cells provides new target for drugs 2
A kit will amplify and hybridize 100 samples. Kit components include: Primers, PCR Buffer, dNTPS, Taq Polymerase, Hybridization Solution, Quick-Light™ Buffer, 20 X SSC Concentrate, Lumi-Phos&re...
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
... II Direct to High Res SSP kits provide high ... tray. Locus specific typing on a single tray reduces ... Straight from genomic DNA to high resolution results, no ... typing with a single tray , Unique reaction pattern ...
Medicine Products: